Results 31 to 40 of about 39,529 (215)

Comparative efficacy and safety of anticoagulants for prevention of venous thromboembolism after hip and knee arthroplasty: A network meta-analysis

open access: yesActa Orthopaedica, 2017
Background and purpose — New oral anticoagulants have been developed to prevent venous thromboembolism (VTE) after knee or hip arthroplasty. Although there have been several network meta-analyses (NMA) to compare different regimens, an NMA including 2 ...
Min Hur   +8 more
doaj   +1 more source

Comparison of Intravenous Enoxaparin with Subcutaneous Enoxaparin in Preventing Venous Thromboembolism in Patients Admitted to Intensive Care Unit

open access: yesArchives of Anesthesia and Critical Care, 2020
Background: The use of subcutaneous enoxaparin is a usual method for preventing venous thromboembolism (VTE) in the intensive care unit (ICU) patients, but adequate absorption of the drug is not reliable due to the illness intensity, existing edema and ...
Masoum Khoshfetrat   +3 more
doaj   +1 more source

Pharmacoequivalence of Enoxaparin and Contaminated Enoxaparin

open access: yesBlood, 2008
Abstract Introduction: Earlier this year, heparin was found to be contaminated with a non-heparin sulfated polymer identified as oversulfated chondroitin sulfate (OSCS). The presence of this contaminant was associated with severe adverse reactions such as hypotension and anaphylaxis, leading to death in some patients.
Jacqueline Kuziej   +6 more
openaire   +1 more source

Double-Blind Randomized Clinical Trial to Examine the Pharmacokinetic and Clinical Impacts of Fixed Dose versus Weight-based Enoxaparin Prophylaxis: A Methodologic Description of the FIxed or Variable Enoxaparin (FIVE) Trial

open access: yesPlastic and Reconstructive Surgery, Global Open, 2019
Venous thromboembolism is an important patient safety in plastic surgery, and multiple clinical trials in the past 10 years have provided increased understanding of the risks and benefits of venous thromboembolism prevention strategies.
Christopher J. Pannucci, MD, MS   +5 more
doaj   +1 more source

Prophylaxis for venous thromboembolic disease in pregnancy and the early postnatal period [PDF]

open access: yes, 2010
Some women are at risk of forming blood clots in a deep vein during pregnancy, after a caesarean birth, or during the first few weeks after childbirth. If part of the clot breaks off and lodges in a blood vessel in the lungs, it can be life-threatening ...
Abou-Nassar   +92 more
core   +1 more source

Update on Extended Treatment for Venous Thromboembolism [PDF]

open access: yes, 2018
The importance of assessing the probability of venous thromboembolism recurrence, a condition that includes deep vein thrombosis and pulmonary embolism, lies in the fact that it is the most important factor in deciding the duration of anticoagulant ...
Del Toro-Cervera, Jorge   +7 more
core   +2 more sources

Comparison of pain after prophylactic anticoagulant injections to prevent venous thromboembolism

open access: yesSurgery Open Science
Subcutaneous injection of unfractionated heparin (UH) or low molecular weight heparin (LMWH) is frequently utilized for venous thromboembolism chemoprophylaxis.
Margaret Shyu   +6 more
doaj   +1 more source

Effects of a single subcutaneous dose of enoxaparin on veterinary viscoelastic coagulation monitor variables in healthy cats: Double blind, placebo controlled cross‐over trial

open access: yesJournal of Veterinary Internal Medicine, 2023
Background Cats placed on anticoagulant medication require frequent monitoring. The veterinary viscoelastic coagulation monitor (VCM‐Vet) could provide a convenient and cost‐effective monitoring, enabling therapeutic decision making.
Ivayla D. Yozova   +2 more
doaj   +1 more source

Enoxaparin, effective dosage for intensive care patients: double-blinded, randomised clinical trial [PDF]

open access: yes, 2010
Udgivelsesdato: 2010-Mar-18ABSTRACT: INTRODUCTION: Intensive care unit (ICU) patients are predisposed to thromboembolism. Routine prophylactic anticoagulation is widely recommended. Low-molecular-weight heparins, such as enoxaparin, are increasingly used
Sian Robinson   +5 more
core   +1 more source

Home - About - Disclaimer - Privacy